MAPT and Dravet syndrome: A total of 93 adults with DS (aged 25–61 years) from the Alzheimer Biomarker Consortium—DS completed cognitive assessments, MRI and positron emission tomography (PET) scans (assessing amyloid-beta [Aβ] and tau), and a one-night home sleep study using the WatchPAT-300 device.